NOTE PURCHASE AGREEMENTNote Purchase Agreement • August 14th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledAugust 14th, 2013 Company Industry JurisdictionThis Note Purchase Agreement (this “Agreement”) is entered into as of June 24, 2013, by and among Fate Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto, as amended from time to time.
NOTE PURCHASE AGREEMENTNote Purchase Agreement • July 29th, 2013 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 29th, 2013 Company Industry JurisdictionThis Note Purchase Agreement (this “Agreement”) is entered into as of June 24, 2013, by and among Fate Therapeutics, Inc., a Delaware corporation (the “Company”), and the purchasers (each, an “Investor” and collectively, the “Investors”) listed on Exhibit A hereto, as amended from time to time.